Communicating COVID-19 vaccines: lessons from the dengue vaccine controversy in the Philippines
In 2016, the Philippines embarked on an unprecedented mass immunisation campaign
against dengue fever, becoming the first Asian nation to authorise the commercial use of
Dengvaxia, the dengue vaccine manufactured by the French pharmaceutical Sanofi Pasteur.
1 In December 2017, nearly 2 years since the campaign started, Sanofi announced that
Dengvaxia may actually cause 'more severe disease'in those who have not had previous
dengue infection. 2 By then, over 800,000 Filipino schoolchildren had been inoculated. 1 …
against dengue fever, becoming the first Asian nation to authorise the commercial use of
Dengvaxia, the dengue vaccine manufactured by the French pharmaceutical Sanofi Pasteur.
1 In December 2017, nearly 2 years since the campaign started, Sanofi announced that
Dengvaxia may actually cause 'more severe disease'in those who have not had previous
dengue infection. 2 By then, over 800,000 Filipino schoolchildren had been inoculated. 1 …
以上显示的是最相近的搜索结果。 查看全部搜索结果